C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 5.55 USD -0.89% Market Closed
Market Cap: 74.4m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CASI Pharmaceuticals Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
Net Change in Cash
$8.4m
CAGR 3-Years
35%
CAGR 5-Years
-27%
CAGR 10-Years
2%
Abbvie Inc
NYSE:ABBV
Net Change in Cash
-$6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$669m
CAGR 3-Years
57%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$25.7B
CAGR 3-Years
N/A
CAGR 5-Years
-116%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$148.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CASI Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
8.4m USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Net Change in Cash amounts to 8.4m USD.

What is CASI Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
2%

Over the last year, the Net Change in Cash growth was 0%. The average annual Net Change in Cash growth rates for CASI Pharmaceuticals Inc have been 35% over the past three years , -27% over the past five years , and 2% over the past ten years .

Back to Top